Pharmaceuticals

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Trend Stats

1-Month Return +5.23%
3-Month Return +11.05%
12-Month Return +26.02%
Volatility Score 1.8
RSI 58.2
ST Trend Up
LT Trend Up

Short-Term Trend

Up

The Short-Term Trend is a metric that gauges an ETF's short-term price trend.

Long-Term Trend

Up

The Long-Term Trend is a metric that gauges an ETF's long-term price trend.

Performance

Pharmaceuticals
S&P 500 Index

Components

Symbol Company Market Cap 12 mo return Performance over the past 12 months 3 mo return Performance over the past 3 months 1 mo return Performance over the past month Vol Score Our gauge of the ETF's recent volatility ST Trend A metric that gauges an ETF's short-term price trend LT Trend A metric that gauges an ETF's long-term price trend
LLY Eli Lilly & Co $1.1T +48.21% +35.54% +7.05% 3.3 Up Up
JNJ Johnson&Johnson $635B +60.42% +16.45% +9.29% 2.5 Up Up
ABBV AbbVie $458B +40.53% +31.45% +11.20% 2.5 Up Up
MRK Merck $324B +59.90% +17.97% +8.68% 2.7 Up Up
NVS Novartis Sp ADR $295B +35.68% +6.56% +1.23% 2.2 Neutral Up
AZN ASTRAZENECA $263B +18.50% -10.80% -7.52% 3.2 Down Down
NVO Nordisk Sp ADR-B $216B -28.81% +18.46% +2.87% 2.5 Up Up
PFE Pfizer $140B +5.93% -5.99% +3.87% 2.0 Down Down
BMY Bristol-MyersSqu $127B +34.36% +6.95% +14.17% 2.6 Up Up
SNY SANOFI SP ADR $104B -9.17% -2.20% +4.89% 2.1 Down Down
GSK GSK Sp ADR $103B +40.32% -4.83% +0.51% 2.4 Down Neutral
MCK Mckesson $98B +18.61% +1.66% +9.70% 2.6 Up Neutral
COR Cencora $60B +7.53% +0.78% +8.94% 2.5 Up Down
TAK TAKEDA PHARM SP ADR $55B +23.83% +3.67% +9.67% 1.7 Up Up
HLN Haleon Sp ADR $43B +0.95% +2.09% +5.96% 1.8 Up Neutral
TEVA TEVAPHARMIND SP ADR $36B +86.28% +0.55% -9.96% 3.4 Down Neutral
ZTS Zoetis-A $32B -49.52% -35.08% -2.94% 3.1 Down Down
VTRS Viatris $20B +90.43% +19.03% +8.22% 2.9 Up Up
JAZZ Jazz Pharmaceuti $16B +114.73% +29.18% +10.45% 2.9 Up Up
ELAN ELANC ANIML HLTH $12B +66.96% +9.49% +3.96% 3.5 Up Up
AXSM Axsome Therapeut $12B +139.02% +29.60% +1.29% 4.0 Neutral Up
CORT Corcept Therapeu $10B +39.64% +107.03% +16.92% 4.4 Up Up
OGN Organon $3.6B +33.59% +20.25% +0.30% 0.4 Neutral Up
BHC BAUSCH HEALTH $1.7B -34.56% -21.31% -11.22% 5.3 Down Down
PRGO Perrigo $1.4B -61.48% -12.42% +3.38% 5.3 Down Down